DK0877612T3 - Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser - Google Patents

Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser

Info

Publication number
DK0877612T3
DK0877612T3 DK93923615T DK93923615T DK0877612T3 DK 0877612 T3 DK0877612 T3 DK 0877612T3 DK 93923615 T DK93923615 T DK 93923615T DK 93923615 T DK93923615 T DK 93923615T DK 0877612 T3 DK0877612 T3 DK 0877612T3
Authority
DK
Denmark
Prior art keywords
treatment
cognitive disorders
pct
piperazine derivatives
date
Prior art date
Application number
DK93923615T
Other languages
Danish (da)
English (en)
Inventor
Ian Anthony Cliffe
Allan Fletcher
Alan Chapman White
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of DK0877612T3 publication Critical patent/DK0877612T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK93923615T 1992-11-05 1993-10-25 Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser DK0877612T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929223153A GB9223153D0 (en) 1992-11-05 1992-11-05 Piperazine derivatives
PCT/GB1993/002197 WO1994009780A1 (en) 1992-11-05 1993-10-25 Use of piperazine derivatives for the treatment of cognitive disorders

Publications (1)

Publication Number Publication Date
DK0877612T3 true DK0877612T3 (da) 2000-10-09

Family

ID=10724559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93923615T DK0877612T3 (da) 1992-11-05 1993-10-25 Anvendelse af piperazinderivater til behandling af cognitive forstyrrelser

Country Status (18)

Country Link
US (1) US5827847A (enExample)
EP (1) EP0877612B1 (enExample)
JP (1) JP3238153B2 (enExample)
AT (1) ATE195422T1 (enExample)
AU (1) AU682155B2 (enExample)
CA (1) CA2148593C (enExample)
DE (1) DE69329252T2 (enExample)
DK (1) DK0877612T3 (enExample)
ES (1) ES2149216T3 (enExample)
GB (1) GB9223153D0 (enExample)
GR (1) GR3034400T3 (enExample)
HU (1) HUT72049A (enExample)
LV (1) LV12734B (enExample)
MX (1) MX9306879A (enExample)
PT (1) PT877612E (enExample)
TW (1) TW252043B (enExample)
WO (1) WO1994009780A1 (enExample)
ZA (1) ZA937827B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710481A1 (en) * 1994-11-02 1996-05-08 Duphar International Research B.V Use of flesinoxan for cognition enhancement
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
GB2222768B (en) * 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0955296A3 (en) * 1989-04-22 2000-01-19 American Home Products Corporation Tertiary alkyl functionalized piperazine derivatives
IL94151A (en) * 1989-04-22 1995-08-31 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity
ATE178893T1 (de) * 1990-01-11 1999-04-15 Upjohn Co 6,7,8,9-tetrahydro-3h-benz(e)indolheterocyclen mit wirkung auf das zentrale nervensystem
GB9022820D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives
DE4039631A1 (de) * 1990-12-12 1992-06-17 Troponwerke Gmbh & Co Kg Neuroprotektive kombination
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
DE4135551A1 (de) * 1991-08-31 1993-03-04 Schering Ag Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen

Also Published As

Publication number Publication date
AU682155B2 (en) 1997-09-25
AU5342194A (en) 1994-05-24
HUT72049A (en) 1996-03-28
MX9306879A (es) 1995-01-31
JP3238153B2 (ja) 2001-12-10
US5827847A (en) 1998-10-27
DE69329252D1 (de) 2000-09-21
ATE195422T1 (de) 2000-09-15
EP0877612A1 (en) 1998-11-18
CA2148593A1 (en) 1994-05-11
PT877612E (pt) 2000-11-30
WO1994009780A1 (en) 1994-05-11
JPH08502743A (ja) 1996-03-26
DE69329252T2 (de) 2001-03-29
EP0877612B1 (en) 2000-08-16
LV12734A (en) 2001-10-20
GR3034400T3 (en) 2000-12-29
GB9223153D0 (en) 1992-12-16
LV12734B (en) 2002-01-20
HU9501290D0 (en) 1995-06-28
CA2148593C (en) 2005-12-06
ES2149216T3 (es) 2000-11-01
ZA937827B (en) 1995-04-21
TW252043B (enExample) 1995-07-21

Similar Documents

Publication Publication Date Title
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
ATE188472T1 (de) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
DK0652871T3 (da) Absorberende artikel med fastgøringssystem, der tilvejebringer dynamisk tilpasning af elasticeret linning
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
GB9300194D0 (en) Piperazine derivatives
DE69424009D1 (de) Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst
ES2123756T3 (es) Derivados de piperazina.
DK0632805T3 (da) Melaminderivater til anvendelse i behandlingen af cancer
SE9202266D0 (sv) Novel piperazine carboxamides
NO972938L (no) Farmasöytiske piperazinforbindelser
ZA941934B (en) Piperazine derivatives
DK0689534T3 (da) Amidderivater som 5-HT1A-ligander
DK1068184T3 (da) N-aryloxyethylaminderivater til behandling af despression
ES2149216T3 (es) Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos.
ATE219083T1 (de) 4-oxo-und 4h-imidazo(5,1-c)(1,4)benzoxazine nützlich als benzodiazepinrezeptor-bindemittel.
ATE198887T1 (de) Substituierte arylthioalkylthiopyridine
SE9603284D0 (sv) New compounds
GB9304632D0 (en) Amide derivatives
MX9603868A (es) Composicion farmaceutica de derivados de indeno para la regulacion de la apoptosis.
DE59309469D1 (de) Triazolochinazoline zur behandlung zentralnervöser erkrankungen